LEEDS research could see the development of a revolutionary new treatment for brain cancer. Around 9,000 people are diagnosed with brain cancer in the UK every year. And while treatments for many cancers have improved in recent years, the prognosis for brain cancer patients has barely changed.
Welcome to the Leeds Institute of Cancer and Pathology
Professor Philip Quirke has been successful (in collaboration with colleagues from Manchester, Sheffield and Newcastle University) in securing the funding.
Associate Professor Steve Griffin has had the above article published on "The Conversation".